For people living with opioid use disorder, the path to treatment is not always clear-cut. Sometimes, there’s no path at all. The gap between those recommended for medications for opioid use disorder — with methadone, buprenorphine or other medications prescribed — and those who ultimately receive it is wide and persisting. At the epicenter, accounting for more than one third of individuals with an opioid disorder, are Medicaid recipients. In an effort to gather information that might help to close that gap, researchers at Brown, including Alexandria Macmadu, a doctoral candidate in epidemiology, analyzed Medicaid databases to identify predictors of timely enrollment in treatment for those who experienced an opioid overdose or were diagnosed with opioid use disorder. Read more.